Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 in Patients with Invasive Fungal Infections that are Refractory to or Intolerant of Standard Antifungal Treatment (FURII)
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
Scynexis Inc
Start Date
November 29, 2016
End Date
September 30, 2024
Administered By
Duke Clinical Research Institute
Awarded By
Scynexis Inc
Start Date
November 29, 2016
End Date
September 30, 2024